Home › B-Cell Lymphoma › Washington › Seattle

Pag-aaral pangklinika para sa B-Cell Lymphoma sa Seattle, WA

Isang pag-aaral para sa B-Cell Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Seattle. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

Nagre-recruitPhase 1

Seattle Children's Hospital, Seattle

Edad 0 hanggang 18 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT06173518

BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL

Nagre-recruitPhase 1

Providence Swedish Cancer Institute, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT05370430

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Nagre-recruitPhase 1

Swedish Cancer Institute (SCI), Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07101328

Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma

Nagre-recruitPhase 2

Fred Hutch/University of Washington Cancer Consortium, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT07097363

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

Nagre-recruitPhase 1

Fred Hutch Cancer Center, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 15, 2026 · NCT06528301

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Nagre-recruitPhase 1/2

Swedish Cancer Institute, Seattle
Fred Hutchinson Cancer Center, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT04104776

DALY II USA/ MB-CART2019.1 for DLBCL

Nagre-recruitPhase 2

Fred Hutchinson Cancer Center, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT04792489

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Nagre-recruitPhase 1

Seattle Children's Hospital, Seattle

Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Dis 6, 2024 · NCT05476770

Pag-aaral para sa B-Cell Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Seattle

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.